Head-to-head · Cost-Efficiency Index
FormBlends vs Nucific
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
FormBlends
Cost-first shoppers who want not applicable as a direct provider -- functions as a research/referral hub, not a prescriber.
Visit FormBlendsNucific
Cost-first shoppers who want not currently recommendable without verified pricing; flag for re-check before publishing a review.
Visit NucificThe verdict
FormBlends and Nucific tie on the Cost-Efficiency Index at 41/100, so neither wins outright on the numbers. For most shoppers we'd start with FormBlends (ranked #519, a hair above #521) — Cost-first shoppers who want not applicable as a direct provider -- functions as a research/referral hub, not a prescriber. But Nucific is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs FormBlends.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | FormBlends | Nucific |
|---|---|---|
| Cost-Efficiency Index | 41/100 | 41/100 |
| Semaglutide / mo | Not disclosed | Not disclosed |
| Tirzepatide / mo | Not disclosed | Not disclosed |
| Semaglutide / yr (modeled) | — | — |
| Tirzepatide / yr (modeled) | — | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #519 | #521 |
FormBlends
41/100Where the value is
- Large self-reported provider directory (7,200+ profiles) and clinical research library
- Transparent about its own limitations, including an explicit pricing-may-be-stale disclaimer
- Claims 47-state coverage via its 503A pharmacy network of partner providers
The tradeoffs
- Not itself a licensed prescriber -- explicitly disclaims being a medical practice
- No verifiable direct pricing; site itself warns its listed provider prices may be outdated
Nucific
41/100Where the value is
- Uses OpenLoop Health, a known legitimate telehealth clinical backend, for prescribing
- Offers real compounded semaglutide and tirzepatide, not just a supplement
- Established consumer brand with existing customer base from its supplement business
The tradeoffs
- No price for the prescription GLP-1 program could be found or verified
- Same brand simultaneously sells an unrelated OTC 'GLP-1 Balance' supplement, high risk of shopper confusion
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.